Not Medicare Enrolled
Dr. James Quarles, MD
Urology Physician · Evans, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quarles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quarles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quarles
Dr. James Quarles is an urology physician in Evans, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Quarles performed 6,059 Medicare services across 2,665 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quarles received a total of $5,598 from 51 pharmaceutical and/or device companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quarles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in GA
$5,598 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,059
Medicare services
Top 16% in GA for urology physician
2,665
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~303 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,300 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,135 | $59 | $161 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
786 | $2 | $25 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 291 | $135 | $700 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
223 | $7 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $86 | $247 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
162 | $8 | $22 |
| PSA test (prostate cancer screening) | 140 | $18 | $51 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
114 | $73 | $231 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
110 | $60 | $700 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
91 | $9 | $100 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
60 | $18 | $51 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
53 | $24 | $125 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $35 | $96 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
41 | $37 | $190 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
39 | $24 | $357 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
37 | $98 | $850 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
34 | $69 | $600 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
23 | $38 | $82 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
22 | $170 | $1,034 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $100 | $368 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
21 | $63 | $225 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $311 | $2,000 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
16 | $396 | $2,500 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
16 | $83 | $948 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
16 | $21 | $60 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
15 | $535 | $2,500 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
12 | $102 | $1,400 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
11 | $34 | $78 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
46.2% medium
53.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,598
Total received (2018-2024)
Avg $800/year across 7 years
Top 40% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,422 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$176 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$854
2023
$961
2022
$926
2021
$993
2020
$371
2019
$823
2018
$671
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$265
Dendreon Pharmaceuticals LLC
$158
Teleflex LLC
$141
Sumitomo Pharma America, Inc.
$118
PFIZER INC.
$85
Laborie Medical Technologies Corp.
$43
ABBVIE INC.
$26
Ethicon US, LLC
$18
Top 3 companies account for 66.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,045
Teleflex LLC
$453
PROCEPT BioRobotics Corporation
$265
Boston Scientific Corporation
$252
Sumitomo Pharma America, Inc.
$250
NeoTract Inc.
$210
Janssen Biotech, Inc.
$208
Myovant Sciences Inc.
$200
PFIZER INC.
$184
Dendreon Pharmaceuticals LLC
$176
UROVANT SCIENCES INC
$159
Bayer HealthCare Pharmaceuticals Inc.
$151
COLOPLAST CORP
$140
Axonics, Inc.
$138
Blue Earth Diagnostics Limited
$137
AbbVie, Inc.
$112
ABBVIE INC.
$103
Coloplast Corp
$99
UroGen Pharma, Inc.
$97
Cook Medical LLC
$96
AbbVie Inc.
$91
Endo Pharmaceuticals Inc.
$87
Bayer Healthcare Pharmaceuticals Inc.
$75
Antares Pharma, Inc.
$74
Janssen Scientific Affairs, LLC
$71
ACCORD HEALTHCARE, INC.
$61
Laborie Medical Technologies Corp.
$61
Travere Therapeutics, Inc.
$59
Allergan Inc.
$53
AstraZeneca Pharmaceuticals LP
$50
Baxter Healthcare
$42
Kowa Pharmaceuticals America, Inc.
$40
Allergan, Inc.
$38
MEDIVATION FIELD SOLUTIONS LLC
$32
TOLMAR Pharmaceuticals, Inc.
$26
Clarus Therapeutics Inc.
$24
C. R. Bard, Inc. & Subsidiaries
$23
Ethicon US, LLC
$18
180 Medical, Inc.
$18
Supernus Pharmaceuticals, Inc.
$17
Foundation Medicine, Inc.
$17
Merck Sharp & Dohme Corporation
$17
Myriad Genetic Laboratories, Inc.
$17
Retrophin, Inc.
$16
Tolmar, Inc.
$15
Smith+Nephew, Inc.
$15
Acerus Pharmaceuticals Corporation
$14
Cardinal Health 414 LLC
$14
Metuchen Pharmaceuticals
$14
Ambu Inc.
$13
Wilmington Medical Supply, Inc.
$13
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AQUABEAM SYSTEM · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · Cook Medical Lasers · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENTLECATH · Harmonic · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LITHOVUE EMPOWER · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PROVENGE · Prolaris · SEGLENTIS · STRAVIX · Seglentis · SpaceOAR System · Stendra · TISSEEL · TITAN · TOVIAZ · Thiola · Titan · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
28
Per 100K population
17.5
County median income
$96,122
Nearest hospital
DOCTORS HOSPITAL
7.9 mi
7.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quarles is a clinical cardiology specialist, with above-average Medicare volume (top 16% in GA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quarles experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Quarles performed 2,300 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quarles receive payments from pharmaceutical companies?
Yes. Dr. Quarles received a total of $5,598 from 51 companies across 225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quarles's costs compare to other urology physicians in Evans?
Dr. Quarles's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quarles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Evans
Browse urology physicians in Evans ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology